Two new dry powder inhalers will soon hit the market
Two new DRY POWDER inhalers will soon hit the market...Glaxo's Flovent Rotadisk and Serevent Diskus.
These have been developed as an alternative to aerosol MDIs...because of the upcoming ban on chlorofluorocarbon propellants.
Dry powder inhalers are also easier for some patients to use. They're breath-activated...patients DON'T have to coordinate their breathing with the actuation of the inhaler.